Your browser is no longer supported. Please, upgrade your browser.
Settings
XPH SPDR S&P Pharmaceuticals ETF daily Stock Chart
XPH [NYSE]
SPDR S&P Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week3.50%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.05%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.72%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.82 Perf Half Y-7.40%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year5.62%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range36.58 - 47.82 Perf YTD8.21%
Dividend0.24 P/FCF- EPS past 5Y- ROI- 52W High-11.54% Beta-
Dividend %0.57% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low15.64% ATR0.72
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)61.20 Volatility1.66% 1.63%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.22 Prev Close42.11
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume245.16K Price42.30
Recom- SMA201.74% SMA503.96% SMA2000.02% Volume54,859 Change0.45%
Mar-27-17 06:04PM  ETF Flyer: Healthcare Stocks Continue To Dance On the Grave Of The Failed GOP Bill at Barrons.com
Mar-20-17 10:22AM  Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar-16-17 03:05PM  Analyzing Bristol-Myers Squibbs 2016 Performance
Mar-15-17 04:33PM  Should You Buy Pharma ETFs Now?
09:05AM  Johnson & Johnsons Financial Guidance for 2017
Mar-14-17 04:03PM  Aurinias stock plunges after big share offering at deep discount at MarketWatch
Mar-08-17 10:07AM  Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs
Mar-07-17 04:05PM  Stocks Fall for Day Two as Trump Targets Health Care Sector
02:24PM  Stock market loses ground as energy shares weigh at MarketWatch
09:16AM  Pharma and biotech stocks slump after President Trump tweets about lowering drug prices at MarketWatch
Mar-06-17 10:36AM  How Mylan Is Valued after 4Q16 Earnings
Mar-01-17 04:14PM  Best & Worst ETFs of February 2017
01:24PM  Investors have stopped believing Trumps drug price threats at MarketWatch
08:23AM  Bernie Sanders has some new allies in fight to bring Canadian drugs to the U.S. at MarketWatch
Feb-27-17 08:22AM  Pieris Pharmaceuticals' stock soars after exclusive license deal with Japan's ASKA at MarketWatch
07:32AM  La Jolla Pharmaceutical's stock rockets in active trade after positive trial results at MarketWatch
Feb-24-17 10:38AM  Eli Lilly & Co.s Cardiovascular Franchise
Feb-23-17 07:47AM  Gardasil Driving Merck & Co.s Vaccines Business in 4Q16
Feb-07-17 04:42PM  Drug stocks dip after Spicer affirms Trumps stance on cutting costs at MarketWatch
Feb-06-17 09:55AM  Q4 Earnings Faring Well for Pharma ETFs
Jan-26-17 09:06AM  What to Expect from Eli Lillys Cardiovascular Franchise in 4Q16
Jan-20-17 09:59AM  A.M. Funds Roundup: Investors Buy Volatility ETFs, Exit Equity ETFs Ahead Of Inauguration, at Barrons.com
Jan-19-17 04:06PM  What Lies Ahead for Pharma ETFs?
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at Barrons.com
Jan-12-17 12:01PM  Biotech ETFs Continue To Bleed at Barrons.com
12:00PM  Trump's First Press Conference Puts These ETFs in Focus
10:37AM  Mylans Specialty Segment: The Effect of Falling EpiPen Sales
Jan-11-17 04:30PM  The Biggest Loser: Endo International Tumbles 8.6% at Barrons.com
01:03PM  2 Stocks For a Trump-ed Up Pharma Market at Barrons.com
12:09PM  Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" at Barrons.com
Dec-20-16 08:19AM  Tesaro NDA for ovarian cancer treatment granted priority review at MarketWatch
07:36AM  It Was a Successful 3Q16 for Horizon Pharmas Primary Care
Dec-16-16 08:37AM  Mylan's first generic EpiPen launches at less than half the cost of branded version at MarketWatch
Dec-14-16 08:05AM  Loss of Patent Protection to Drag Pfizers Top Line
Dec-12-16 09:36AM  Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer
Dec-09-16 07:26AM  Express Scripts stock rocked by tweets from short seller Andrew Left at MarketWatch
Dec-08-16 03:00PM  Biotech & Pharma ETFs to Suffer in 2017 Too?
01:43PM  Express Scripts' stock dives after short seller Andrew Left takes aim at MarketWatch
Dec-07-16 02:11PM  President-elect Trumps promise to bring down drug prices sends biotech and pharma ETFs slumping at MarketWatch
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
11:31AM  Biotech ETFs: So Much For The Trump Bounce at Barrons.com
Dec-05-16 11:05AM  Inside Mercks Profitability after 3Q16
Dec-02-16 04:05PM  Two Nano-Cap Pharma Stocks To Watch Right Now at Insider Monkey
10:49AM  5 Secret Santa ETFs & Stocks for Your Portfolio
Dec-01-16 08:51AM  Five ways to evaluate an Obamacare replacement plan at MarketWatch
08:50AM  What to expect from HHS Secretary nominee and Obamacare opponent Tom Price at MarketWatch
Nov-30-16 06:21PM  A Closer Look at Mercks Valuation Compared to Peers
Nov-27-16 04:54PM  Where Else Have We Seen Mallinckrodts Acquire to Invest Strategy?
Nov-23-16 10:04AM  What You Need to Know about Eli Lillys Cardiovascular Franchise
Nov-22-16 11:04AM  What Do the Analysts Recommend for Bristol-Myers Squibbs Stock?
Nov-17-16 12:18PM  Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
Nov-16-16 08:15AM  Biotech takes Trump presidency as a green light and end to drug price worries at MarketWatch
Nov-14-16 10:57AM  5 Reasons to Buy 5 Low P/E Biotech ETFs
07:52AM  Corbus Pharmaceuticals stock more than doubles after positive drug trial results at MarketWatch
Nov-04-16 01:15PM  Healthcare: "A Better Buy Than A Sell" at Barrons.com
Oct-31-16 05:39PM  Can Key Level Stop The Bleeding In Health Care Stocks?
10:05AM  Understanding the Growth Contributors in Pfizers 3Q16 Estimates
10:04AM  Januvia and Janumet: Mercks Blockbuster Diabetes Products
Oct-20-16 05:48PM  Another Health Care Chart Looks Sick
08:04AM  Eli Lilly and Co.s 3Q16 Estimates: Cardiovascular Franchise
Oct-12-16 10:04AM  BMYs Drug Treatments That Go beyond Immuno-Oncology
Oct-10-16 11:04AM  Keytruda Leads over Opdivo in Head and Neck Cancer Treatment
Oct-04-16 10:04AM  A Look at Gardasil and Merck & Co.s Vaccines Business
Oct-03-16 08:05AM  Medicare Negotiations Would Lead to Huge Cost Savings
Sep-30-16 03:04PM  Analyzing Donald Trumps Free-Market Healthcare
11:15AM  Generic Drugs Are Crucial in Cost Savings and Accessibility
Sep-27-16 02:20PM  Getting Into The Drug Business: From NDAs To PDUFA Dates
Sep-26-16 11:05AM  How Mylans Profitability Has Changed
Sep-23-16 03:20PM  Are Mylans EpiPen Challenges Souring Analysts Views on Stock?
02:23PM  Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO
Sep-21-16 11:05AM  How Analysts See Horizon Compared to Its Peers
Sep-20-16 12:04PM  News of Acquisition Caused Horizon Pharma Stock to Rise
Sep-19-16 06:50PM  A Breakdown Here In This Sector Would Not Be Healthy
Sep-12-16 02:47PM  M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound
09:30AM  The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
Sep-09-16 03:39PM  Will a Clinton Presidency Spell Doom for Pharma ETFs?
Sep-06-16 11:22AM  Top Sector ETFs of Summer
Sep-05-16 11:04AM  Animal Health: Just as Important to Eli Lilly as Human Health
Aug-31-16 10:05AM  Why Pfizer Is Trading at a Discount on an Earnings Basis
Aug-30-16 10:04AM  Akorn in 2016: What Are Its Key Risk Factors?
Aug-24-16 11:04AM  How Did Bristol-Myers Squibb Fare in 2Q16?
Aug-22-16 09:06AM  How Did Bristol-Myers Squibbs Oncology Segment Perform in 2Q16?
Aug-19-16 11:04AM  Horizons Orphan Drug Business Faces These Opportunities
Aug-15-16 09:06AM  What Are Mercks Key Diabetes Products?
Aug-07-16 01:20PM  Obamacare Still Sickly, After All These Years
Aug-04-16 09:04AM  Eli Lillys Cardiovascular Franchise Keeps Posting Upbeat Revenues
Aug-03-16 12:22PM  Pharma ETFs Soaring on Solid Q2 Earnings
Jul-26-16 09:04AM  What Key Developments Did JNJ Announce in 2Q16?
Jul-25-16 02:24PM  Expectations for Bristol-Myers Squibbs 2Q16 Earnings
Jul-22-16 01:07PM  Inside Lillys 2Q16 Estimates for Its Cardiovascular Franchise
Jul-21-16 11:08AM  Best Sector ETFs for Q3
Jul-15-16 09:06AM  Jazz Pharmaceuticals: How Much Return Potential Does It Have?
Jul-12-16 11:06AM  Check out Horizons Huge Upside Potential
Jul-07-16 07:06AM  Whats Really Driving Horizons Valuation?
May-20-16 10:05AM  Keytruda: Mercks Immuno-Oncology Blockbuster Drug
09:30AM  Pharmaceuticals & Emerging Market: Two ETFs Trading with Outsized Volume
May-12-16 10:09AM  Januvia and Janumet: Mercks Blockbuster Diabetes Drugs
May-11-16 03:47PM  Mercks Valuation Cheat Sheet for Fiscal 1Q16
May-07-16 10:01AM  Mudslinging Over Valeant Pharmaceuticals
May-05-16 08:05PM  How Eli Lillys Cardiovascular Franchise Performed in 1Q16
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.